Home - Products - Tyrothricin


Tyrothricin contains about 20% gramicidin and 80% tyrocidine and belongs to the family of polypeptide antibiotics. It is active against a variety of gram-positive bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus and bacteria causing diphtheria.

Indication: Used in the treatment of local infections; mainly infections of the mouth, throat and superficial skin wounds.

Application: Formulated alone or as a combination drug product used in lozenges and topicals.


Product grades



Ph. Eur.

(Due to Tyrothricin monograph removal from US Pharmacopoeia, USP grade Tyrothricin product is no longer available.)

Manufacturing site

Xellia Pharmaceuticals Ltd., Budapest, Hungary

Release site

Xellia Pharmaceuticals Ltd., Budapest, Hungary

Site registered

EU GMP issued by Hungarian National Institute of Pharmacy recognized by FDA from March 1st 2018 according to Mutual Recognition Agreement (MRA)

Regulatory documentation

EU Drug Master File (DMF)/Certificate of Suitability (CEP)

DMF also available in other selected countries outside EU

Packaging sizes

500 g

10 kg

Ballmilled: Minimum order qty is 40 kg. Ordered quantity should be multiply with 40 kg, 80 kg, 120 kg etc.

Packaging material

Primary: Polyethylene bag closed with twist tie plastic clip

Secondary: Heat sealed multi-layer laminated aluminum bag

Shelf life

5 years

Storage conditions

Do not store above 25 °C (77 °F)